Domestic and foreign market price comparison and purchasing options of Sotoracib (AMG510) in 2024

Sotorasiib, also known asAMG510, is a targeted therapy drug that targets certain cancer mutations, and its potential therapeutic effect has attracted widespread attention in the treatment of certain tumors. Although sotoracib has not yet received official marketing authorization in China, making it impossible for local patients to purchase it directly from pharmacies, they still have the opportunity to obtain the drug through international channels.

In the international pharmaceutical market, there are two main types of sotorasibu: original drugs and generic drugs, and their prices are significantly different. Specifically, original drugs, including the European version and the Hong Kong version, often cost tens of thousands or more due to their advanced production processes and technical features. This undoubtedly sets a considerable financial threshold for many patients seeking treatment.

However, for patients with limited budgets, generic drugs already available overseas offer a more economical option. Recently, the prices of generic drugs produced by Lucius and Daxiong Pharmaceutical Factories in Laos, for example, have been significantly reduced. Today, patients may pay only about one thousand to two thousand dollars to get the drug. Compared with original drugs, the price of generic drugs is obviously more affordable, reducing the financial burden on patients.

Importantly, there is no significant difference in core ingredients between original drugs and generic drugs, so their therapeutic effects and safety are roughly equivalent. This means that price can be taken more into account when choosing a drug without having to worry too much about the quality of the drug.

To sum up, even if sotoracib has not yet been officially launched in China, patients can still obtain it through international channels. In the international market, although original drugs are expensive, the affordable prices of generic drugs provide more options for patients who need treatment with this drug. Therefore, patients can make informed decisions based on their actual situation and financial situation when choosing.